ImmunityBio
IBRX----
ImmunityBio (IBRX)
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the pati...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ImmunityBio Analyst Rating
View MoreForecast & Rating
Jun 2, 2026Price forecast
$13.0083.10%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 8 hours ago
Aggregation, Scale, and the Value Chain: Decoding Ten Diverse Business Models
- Global Report · 1 day ago, 04:17 AM
Inside the Biotech Sector's Recent Clinical Catalyst Wave
- Global Report · 1 day ago, 04:14 AM
monday.com's AI Pivot and Tron's Token Buildup Highlight Small-Cap Realignments
- Global Report · 2 days ago, 04:13 AM
The 2026 Biotech Divide: When Generative Biology Meets the FDA Wall
- Global Report · Jul 22 at 04:18 AM
Ripping Up the Playbook: The Radical Strategic Pivots Reshaping the Market
- Simplywall · Jul 15 at 04:13 AM
Are Surging IBRX Retail Debates Hinting at a Deeper Re‑rating of ImmunityBio’s Platform?
